Tracy s. Warren, General Partner
Tracy Warren is a general partner of Battelle Ventures and its affiliate fund, Innovation Valley Partners, for which she focuses on investments in health & life sciences, as well as emerging energy technologies, with an emphasis on institutional-based transactions.
Ms. Warren has worked closely with the technology transfer and economic development organizations in medical centers, universities and laboratories, including six of the U.S. Department of Energy National Laboratories, and the Health and Life Sciences division of Battelle Memorial Institute, the world's largest nonprofit research and development organization.
She advises on new-company formation; equity and valuation; intellectual property review, triage and development; technology maturation program development; commercial business strategies; evaluation of potential development partners and/or licensees; mergers and acquisitions; and identification of technology transfer best practices.
Alongside Dr. Cymbeline Culiat, Ms. Warren co-founded NellOne Therapeutics, a soft-tissue regenerative medicine company based on the NELL1 gene and Dr. Culiat's work at Oak Ridge National Laboratory. As CEO, she leads the company's efforts with respect to strategy, fundraising, business development and licensing.
She also co-founded other life sciences companies, such as UPenn spin-out Endovalve (cardiovascular devices), which merged with Micro Interventional Devices, on whose board Ms. Warren sits. And she has led investments in others, such as NuPathe (CNS specialty pharmaceutical), which completed its IPO in 2010, and BioNano Genomics (genetic analysis), of which she is board chairman. On the energy front, as a strong syndicate partner, Ms. Warren also led the funds' investment in SmartSynch (utility smart metering), which was acquired in 2012 by Itron, Inc. for $100 million.
In addition to her investment activities, she also provides early-stage leadership to other businesses, currently serving as an adviser to PDX Pharmaceuticals, LLC, and is a mentor to female entrepreneurs at such innovative companies as TalkSession, TrueMotion Spine, and Life Cycle Laboratories, through Springboard Enterprises.
Ms. Warren is also applying her expertise in technology transfer and intellectual property as a member of the South Carolina-based Clemson University Research Foundation (CURF) Board of Dirctors. CURF is a nonprofit organization dedicated to moving technology from the Clemson lab into commercial markets.
Ms. Warren started in venture capital more than a decade ago, after being an associate in SG Cowen (now Cowen and Company) Securities & Health Care Mergers and Acquisitions and Corporate Finance divisions. She holds a B.S. degree from New York University Stern School of Business and an M.B.A from Columbia Business School, and is a member of the National Association of Corporate Directors.